Intraplatelet L-Arginine-Nitric Oxide Metabolic Pathway: From Discovery to Clinical Implications in Prevention and Treatment of Cardiovascular Disorders
Despite the development of new drugs and other therapeutic strategies, cardiovascular disease (CVD) remains still the major cause of morbidity and mortality in the world population. A lot of research, performed mostly in the last three decades, revealed an important correlation between “classical” d...
Main Authors: | Jakub Gawrys, Damian Gajecki, Ewa Szahidewicz-Krupska, Adrian Doroszko |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2020/1015908 |
Similar Items
-
Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus
by: Jakub Gawryś, et al.
Published: (2020-01-01) -
A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus
by: Damian Gajecki, et al.
Published: (2021-07-01) -
Novel Molecular Mechanisms of Pulmonary Hypertension: A Search for Biomarkers and Novel Drug Targets—From Bench to Bed Site
by: Damian Gajecki, et al.
Published: (2020-01-01) -
Cardiovascular Disorders Triggered by Obstructive Sleep Apnea—A Focus on Endothelium and Blood Components
by: Jakub Mochol, et al.
Published: (2021-05-01) -
Role of the Platelets and Nitric Oxide Biotransformation in Ischemic Stroke: A Translative Review from Bench to Bedside
by: Maciej Bladowski, et al.
Published: (2020-01-01)